Advertisement
Advertisement

RMD

RMD logo

ResMed Inc.

255.06
USD
Sponsored
+0.32
+0.12%
Feb 03, 09:53 UTC -5
Open

RMD Earnings Reports

Positive Surprise Ratio

RMD beat 27 of 40 last estimates.

68%

Next Report

Date of Next Report
Apr 21, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.42B
/
$2.80
Implied change from Q2 26 (Revenue/ EPS)
--
/
-0.36%
Implied change from Q3 25 (Revenue/ EPS)
+10.15%
/
+18.14%

ResMed Inc. earnings per share and revenue

On Jan 29, 2026, RMD reported earnings of 2.81 USD per share (EPS) for Q2 26, beating the estimate of 2.75 USD, resulting in a 2.15% surprise. Revenue reached 1.42 billion, compared to an expected 1.41 billion, with a 0.89% difference. The market reacted with a +0.27% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 17 analysts forecast an EPS of 2.80 USD, with revenue projected to reach 1.42 billion USD, implying an decrease of -0.36% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
logo
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
logo
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
FAQ
For Q2 2026, ResMed Inc. reported EPS of $2.81, beating estimates by 2.15%, and revenue of $1.42B, 0.89% above expectations.
The stock price moved up 0.27%, changed from $257.61 before the earnings release to $258.31 the day after.
The next earning report is scheduled for Apr 21, 2026.
Based on 17 analysts, ResMed Inc. is expected to report EPS of $2.80 and revenue of $1.42B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement